1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Alliance for Chronic Diseases (GACD): Multimorbidity Research is sponsored by National Institutes of Health (NIH) Fogarty International Center (in collaboration with GACD members). This initiative supports research on multimorbidity in low- and middle-income countries. It aims to develop and implement interventions to address the challenges of individuals living with multiple chronic conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Global Alliance for Chronic Diseases - Fogarty International Center @ NIH NIH Websites Are Changing Global Alliance for Chronic Diseases Global Alliance for Chronic Diseases (GACD) , a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations. GACD-supported projects .
NCD Multimorbidity Research in LMICs and US Tribal Populations The current NIH-GACD Funding Opportunity Announcement supports applications that aim to improve the availability of effective, equitable, efficient, integrated, patient-centered, safe, and timely care for people living with multiple long-term conditions (non-communicable disease (NCD) multimorbidity) in low- and middle-income countries (LMICs) and/or within American Indian/Alaska Native (AI/AN) populations in the United States.
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) (PAR-25-213) Frequently Asked Questions (FAQs) Watch the Pre-Application Technical Assistance Webinar Fogarty hosted a pre-application technical assistance webinar to aid potential applicants for the NCD Multimorbidity Research in LMICs and US Tribal Populations (PAR-25-213) on November 12, 2024.
Watch pre-application webinar Topic Focus Noncommunicable Disease (NCD) Prevention in Cities Implementation research to reduce the risks of NCDs in the context of cities in low- and middle-income countries (LMICs) and among American Indian/Alaska Native (AI/AN) populations in US cities, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally.
Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods Primary and Secondary Prevention of Cancer Primary and secondary prevention of cancer in low- and middle-income countries (LMICs), and in populations facing conditions of vulnerability in high-income countries.
Scaling-up Evidence-based Interventions Scaling-up evidence-based interventions at the population level for the prevention or management of hypertension or diabetes.
Child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries and/or in vulnerable populations in high-income countries. Address lung diseases related to environmental exposures , including indoor and outdoor air pollution and tobacco.
Improving the science around implementation of existing interventions for type 2 diabetes. Improve the implementation of existing approaches to prevention and control of hypertension.
Related Information & Resources GACD Pre-Application Technical Assistance Webinars GACD open access resources Chronic, noncommunicable diseases information and resources NIH-funded trial to assess benefits of clean cookstoves NIH-funded trial to assess benefits of clean cookstoves
According to the current listing, eligibility includes: Researchers and institutions in low- and middle-income countries. Confirm the full requirements in the official notice before applying.
Global Alliance for Chronic Diseases (GACD): Multimorbidity Research is funded by National Institutes of Health (NIH) Fogarty International Center (in collaboration with GACD members). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
With Forms J in FY2027, NIH will no longer accept letters of support — the boilerplate endorsements applicants have padded proposals with for decades. Notice NOT-OD-26-094 replaces them with letters of collaboration, aligning NIH with NSF. Here is exactly what changes, what a compliant letter must now contain, who can no longer write one, and how this fits the broader re-engineering of the NIH application package.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article